Current Cardiology Reports

, 15:392

Renal Denervation for Arrhythmias: Hope or Hype?

  • Jonathan S. Steinberg
  • Evgeny Pokushalov
  • Suneet Mittal
Invasive Electrophysiology and Pacing (J Singh, Section Editor)

DOI: 10.1007/s11886-013-0392-0

Cite this article as:
Steinberg, J.S., Pokushalov, E. & Mittal, S. Curr Cardiol Rep (2013) 15: 392. doi:10.1007/s11886-013-0392-0
Part of the following topical collections:
  1. Topical Collection on Invasive Electrophysiology and Pacing

Abstract

Renal artery denervation (RDN) has been introduced as an ablation procedure that can effectively treat drug-resistant forms of hypertension. The ablative lesions reduce the afferent and efferent sympathetic nerve traffic to and from the kidneys, thus improving blood pressure control. Because of better control of blood pressure, and because the procedure reduces central sympathetic output to sensitive structures within the cardiovascular system, it has been hypothesized that RDN may be a valuable antiarrhythmic intervention. Preliminary results using RDN for atrial fibrillation control are promising. This review focuses on the mechanisms by which RDN may function as an antiarrhythmic treatment and early clinical results.

Keywords

Renal artery denervation Antiarrhythmia Atrial fibrillation Ventricular tachycardia Arrhythmias 

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Jonathan S. Steinberg
    • 1
    • 2
    • 4
  • Evgeny Pokushalov
    • 3
  • Suneet Mittal
    • 1
    • 2
  1. 1.Arrhythmia Institute, Valley Health SystemColumbia University College of Physicians & SurgeonsNew YorkUSA
  2. 2.Arrhythmia Institute, Valley Health SystemColumbia University College of Physicians & SurgeonsRidgewoodUSA
  3. 3.State Research Institute of Circulation PathologyNovosibirskRussia
  4. 4.New YorkUSA

Personalised recommendations